Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes"
- PMID: 32188985
- DOI: 10.1210/clinem/dgaa143
Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes"
Comment in
-
Response to Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes".J Clin Endocrinol Metab. 2020 Jun 1;105(6):e2317-8. doi: 10.1210/clinem/dgaa144. J Clin Endocrinol Metab. 2020. PMID: 32188993 Free PMC article. No abstract available.
Comment on
-
Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes.J Clin Endocrinol Metab. 2019 Nov 1;104(11):5499-5506. doi: 10.1210/jc.2019-00423. J Clin Endocrinol Metab. 2019. PMID: 31265074
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical